Colchicine Dosage and Treatment Regimen for Gout
For acute gout flares, the recommended dosage of colchicine is 1.2 mg at the first sign of the flare, followed by 0.6 mg one hour later (total 1.8 mg over one hour), which should be initiated within 36 hours of symptom onset for maximum effectiveness. 1, 2
Acute Gout Treatment
Timing and Initial Dosing
- Colchicine should be initiated as early as possible, ideally within 36 hours of symptom onset for maximum effectiveness 1, 3
- The FDA-approved regimen for acute gout flares is 1.2 mg (two tablets) at the first sign of flare followed by 0.6 mg (one tablet) one hour later 2
- Higher doses have not been found to be more effective, and the maximum recommended dose for treatment of gout flares is 1.8 mg over a one-hour period 2
- Patients typically experience initial pain improvement within 12-24 hours after the first dose 3
Continuation of Treatment
- After the initial loading dose, patients may continue with prophylactic dosing (0.6 mg once or twice daily) 12 hours later until the gout attack resolves 1
- For countries where 1.0 mg or 0.5 mg tablets are available instead of 0.6 mg, the recommended dosing is 1.0 mg as loading dose, followed by 0.5 mg one hour later 1
Efficacy and Response
- Low-dose colchicine (1.8 mg over 1 hour) has been shown to be as effective as higher doses but with significantly fewer side effects 2, 4
- Inadequate response is defined as less than 20% improvement in pain score within 24 hours or less than 50% improvement at 24 hours 3
- If insufficient improvement occurs within 24 hours, consider adding or switching to an alternative therapy 3
Prophylaxis of Gout Flares
- The recommended dosage for prophylaxis of gout flares is 0.5-1 mg/day (0.6 mg once or twice daily) 1, 2
- Prophylactic therapy is recommended during the first 6 months of urate-lowering therapy 1, 2
- The maximum recommended dose for prophylaxis of gout flares is 1.2 mg/day 2
Dose Adjustments for Special Populations
Renal Impairment
- Colchicine should be avoided in patients with severe renal impairment 1
- Dosage should be adjusted according to creatinine clearance in patients with renal impairment 1, 2
Drug Interactions
- Colchicine should not be given to patients receiving strong P-glycoprotein and/or CYP3A4 inhibitors such as cyclosporin or clarithromycin 1
- Dose reduction is necessary when colchicine is co-administered with drugs known to inhibit CYP3A4 and/or P-glycoprotein 2
Elderly and Comorbidities
- In patients with multiple comorbidities, hepatic impairment, or advanced age, dose reduction may be necessary 1
- Patients and physicians should be aware of potential neurotoxicity and/or muscular toxicity with prophylactic colchicine, especially in those with renal impairment or on statin treatment 1
Common Pitfalls and Caveats
- The older high-dose regimen (1 mg loading dose followed by 0.5 mg every 2-3 hours) causes serious gastrointestinal side effects, especially diarrhea, and should be avoided 1, 4
- Colchicine is most effective when started early in the course of an acute attack (within 36 hours, preferably within 12 hours) 1, 3
- Colchicine is not an analgesic medication and should not be used to treat pain from other causes 2
- The safety and efficacy of repeat treatment for gout flares has not been fully evaluated 2
- During an acute gout flare while on prophylactic colchicine, patients may still take the acute treatment dose (1.2 mg followed by 0.6 mg one hour later), then wait 12 hours before resuming the prophylactic dose 2